ArticleNature communications2026
Heterogeneous photocatalyst enables large-scale broadband light-driven atom transfer radical polymerization with high oxygen and inhibitor tolerance.
Article in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
Abstract
Reversible-deactivation radical polymerization (RDRP) is a cornerstone of polymer industry. Normally, RDRPs are highly sensitive to oxygen and inhibitors, which hamper their industrial applications. Present methods cannot achieve facile polymerization in presence of both oxygen and inhibitors, particularly for large-scale production. Herein, we present phenanthroline-based conjugated hypercrosslinked polymer (Phen-CHCP) that serves as an efficient photocatalyst for photoinduced copper-catalyzed atom transfer radical polymerization (Cu-ATRP), exhibiting high tolerance toward oxygen and common polymerization inhibitors. Investigation indicated that heterogeneous nature enables the fast and direct initiator activation in the presence of photoexcited Phen-CHCP, not only accelerating the Cu-catalyzed redox cycle but also stabilizing the phenol inhibitor. As a result, various monomers achieved >95% conversions under broadband lights irradiation. This development strongly encourages large-scale in situ copolymerization and synthesized poly((2-methoxyethyl) acrylate-block-n-butyl acrylate) at 20 L scale (conversion 96%, Đ = 1.26), which highlights the strong potential for industrial applications.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.